OncoTargets and Therapy · 2019 · 12 citations · 26 references
MedicineOncologyRadiation OncologyThoracic ImagingThoracic OncologyTreatment PlanningConcurrent ChemoradiationEsophageal CancerRadiation PneumonitisRadiation TherapyRadiation Treatment PlanningThoracic Oncology Imaging18F-fluorodeoxyglucose Positron Emission TomographyConcurrent Chemoradiation TherapyNeoadjuvant ChemoradiationNeoadjuvant ChemoradiotherapyNeoadjuvant Concurrent ChemoradiationRadiation Dose ConstraintsRadiomicsTherapy Response Evaluation
Purpose: This study integrated clinical outcomes and radiomics of advanced thoracic esophageal squamous cell carcinoma patients receiving neoadjuvant concurrent chemoradiotherapy (NACCRT) to establish a novel constraint model for predicting radiation pneumonitis (RP). Patients and methods: We conducted a retrospective review for thoracic advanced esophageal cancer patients who received NACCRT. From 2013 to 2018, 89 patients were eligible for review. Staging workup and response evaluation included positron emission tomography/computed tomography (PET/CT) scans and endoscopic ultrasound. Patients received RT with 48 Gy to gross tumor and 43.2 Gy to elective nodal area in simultaneous integrated boost method divided in 24 fractions. Weekly platinum-based chemotherapy was administered concurrently. Side effects were evaluated using CTCAE v4. Images of 2-fluoro-2-deoxyglucose PET/CT before and after NACCRT were registered to planning CT images to create a region of interest for dosimetry parameters that spatially matched RP-related regions, including V 10 , V 20 , V 50% , V 27 , and V 30 . Correlation between bio-physic parameters and toxicity was used to establish a constraint model for avoiding RP. Results: Among the investigated cohort, clinical downstaging, complete pathological response, and 5-year overall survival rates were 59.6%, 40%, and 34.4%, respectively. Multivariate logistic regression analysis demonstrated that each individual set standardized uptake value ratios (SUVRs), neither pre- nor post-NACCRT, was not predictive. Interestingly, cutoff increments of 6.2% and 8.9% in SUVRs (delta-SUVR) in registered V 20 and V 27 regions were powerful predictors for acute and chronic RP, respectively. Conclusion: Spatial registration of metabolic and planning CT images with delta-radiomics analysis using fore-and-aft image sets can establish a unique bio-physic prediction model for avoiding RP in esophageal cancer patients receiving NACCRT. Keywords: esophageal cancer, neoadjuvant concurrent chemoradiation, radiation pneumonitis, PET/CT, constraint model
26
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.6K citations
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Florian Lordick, C. Mariette, Karin Haustermans et al. · Annals of Oncology · 2016 · 1.1K citations · Full text